Advances in Chinese and Western medicine for idiopathic dwarfism

Yu Zhong; Yaxiong Guo; Yarong Hao

doi:10.23977/medsc.2022.030117

Advances in Chinese and Western medicine for idiopathic dwarfism

Download as PDF

DOI: 10.23977/medsc.2022.030117 | Downloads: 8 | Views: 720

Author(s)

Yu Zhong ¹, Yaxiong Guo ², Yarong Hao ¹

Affiliation(s)

¹ Shaanxi University of Traditional Chinese Medicine, Xianyang, 712046, China
² Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine, Xianyang, 712046, China

Corresponding Author

Yu Zhong

ABSTRACT

In recent years, with the improvement of living standards, the nutritional status of children in China has improved significantly, but the situation of short stature in children is still not optimistic, short stature and malnutrition are still relatively common problems in the process of children's physical growth, especially in preschool children, therefore, the author summarizes the research progress of Chinese and Western medicine in the treatment of short stature in children, so as to guide the clinical treatment of short stature in children.

KEYWORDS

Idiopathic short stature, Chinese and Western medicine treatment, research progress

CITE THIS PAPER

Yu Zhong, Yaxiong Guo, Yarong Hao, Advances in Chinese and Western medicine for idiopathic dwarfism. MEDS Clinical Medicine (2022) Vol. 3: 93-100. DOI: http://dx.doi.org/10.23977/medsc.2022.030117.

REFERENCES

[1] Shen YN, Wang MUTI. Guidelines for the diagnosis and treatment of children with short stature[J]. Chinese Journal of Pediatrics, 2008(06): 428-430.
[2] Vasques GA, Andrade NLM, Jorge AAL. genetic causes of isolated short stature. arch Endocrinol Metab. 2019 Feb; 63(1): 70-78. doi: 10.20945/2359- 3997000000105. pmid: 30864634.
[3] Vasques GA, Andrade NLM, Jorge AAL. genetic causes of isolated short stature. arch Endocrinol Metab. 2019 Feb;63(1):70-78. doi: 10.20945/2359- 3997000000105. pmid: 30864634.
[4] Gkourogianni A, Andrew M, Tyzinski L, Crocker M, Douglas J, Dunbar N, Fairchild J, Funari MF, Heath KE, Jorge AA, Kurtzman T, LaFranchi S, Lalani S, Lebl J , Lin Y, Los E, Newbern D, Nowak C, Olson M, Popovic J, Pruhová Š, Elblova L, Quintos JB, Segerlund E, Sentchordi L, Shinawi M, Stattin EL, Swartz J, Angel AG, Cuéllar SD, Hosono H, Sanchez-Lara PA, Hwa V, Baron J, Nilsson O, Dauber A. Clinical Characterization of Patients With Autosomal Dominant Short Stature due to Aggrecan Mutations. j Clin Endocrinol Metab. 2017 Feb 1;102(2):460-469. doi: 10.1210/jc.2016-3313. PMID: 27870580; PMCID: PMC5413162.
[5] Quintos JB, Guo MH, Dauber A. Idiopathic short stature due to novel heterozygous mutation of the aggrecan gene. j Pediatr Endocrinol Metab. 2015 Jul;28 (7-8):927-32. doi: 10.1515/jpem-2014-0450. PMID: 25741789; PMCID: PMC4501863
[6] Hisado-Oliva A, Ruzafa-Martin A, Sentchordi L, Funari MFA, Bezanilla-López C, Alonso-Bernáldez M, Barraza-García J, Rodriguez-Zabala M, Lerario AM, Benito-Sanz S, Aza-Carmona M, Campos-Barros A, Jorge AAL, Heath KE. Mutations in C-natriuretic peptide (NPPC): a novel cause of autosomal dominant short stature. Genet Med. 2018 Jan;20(1):91-97. doi: 10.1038/gim.2017.66. Epub 2017 Jun 28. PMID: 28661490.
[7] Vasques GA, Amano N, Docko AJ, Funari MF, Quedas EP, Nishi MY, Arnhold IJ, Hasegawa T, Jorge AA. Heterozygous mutations in natriuretic peptide receptor -B (NPR2) gene as a cause of short stature in patients initially classified as idiopathic short stature. j Clin Endocrinol Metab. 2013 Oct;98(10):E1636- 44. doi: 10.1210/jc.2013-2142. epub 2013 Sep 3. PMID: 24001744.
[8] Hisado-Oliva A, Ruzafa-Martin A, Sentchordi L, Funari MFA, Bezanilla-López C, Alonso-Bernáldez M, Barraza-García J, Rodriguez-Zabala M, Lerario AM, Benito-Sanz S, Aza-Carmona M, Campos-Barros A, Jorge AAL, Heath KE. Mutations in C-natriuretic peptide (NPPC): a novel cause of autosomal dominant short stature. Genet Med. 2018 Jan; 20(1): 91-97. doi: 10.1038/gim.2017.66. Epub 2017 Jun 28. PMID: 28661490.
[9] Liu H T,Jin W B,Wang X,Zheng W X. Analysis of the etiology of 176 cases of dwarfism in children[J]. Guangming TCM, 2013, 28(06): 1186-1187.
[10] Lu Chen, Ni Xiaoyan, Qin Jiandong, Wang Bing, Song Lihua. Development, application and research perspectives of human growth hormone [J]. Journal of Biology,2020,37(05):103-107.
[11] Wang Shuhua. Clinical efficacy analysis of recombinant human growth hormone in the treatment of idiopathic dwarfism in children [J]. Disease Surveillance and Control,2020,14(5):358-360. doi:10.19891/j.issn1673-9388.(2020) 05-0358-03.
[12] JUAN F SOTOS, NAOMI J TOKAR. Growth hormone significantly increases the adult height of children with idiopathic short stature: comparison of subgroups and benefit [J]. International journal of pediatric endocrinology, 2014 (Jan./Dec.): 1-24.
[13] Liu H L,Zhang J,Li F M. Efficacy of rhGH in the treatment of children with idiopathic short stature and its effect on IGF-1 levels[J]. China Maternal and Child Health Research,2021,32(12):1867-1870.
[14] Lanes R, Gunczler P. Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children Clin Endocrinol (Oxf). 1998 Aug; 49(2): 197-202. doi: 10.1046/j.1365-2265.1998. 00499.x. PMID: 9828907.
[15] Wang CHL, Fu JF, Liang L. Advances in drug research for improving adult height in children with dwarfism[J]. Chinese Journal of Practical Pediatrics, 2020, 35(06): 460-464.
[16] HERO M, NORJAVAARA E, DUNKEL L. Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature: a randomized controlled trial.[J]. The Journal of Clinical Endocrinology and Metabolism,2005,90(12):6396-6402.
[17] Wang CHL,Liang L. Third-generation nonsteroidal aromatase inhibitors in pediatric endocrine clinical applications reawakened [J]. Journal of Zhejiang University (Medical Edition),2020,49(03): 275-282.
[18] Qi H T, Zhao F, Wang L, Zhang Q. Analysis of the effectiveness of adjusting recombinant human growth hormone for idiopathic dwarfism based on insulin-like growth factor levels [J]. Chinese Journal of Clinical Physicians (Electronic Edition),2016,10(14):2054-2057.
[19] Grimberg A, DiVall SA, Polychronakos C, Allen DB, Cohen LE, Quintos JB, Rossi WC, Feudtner C, Murad MH; Drug and Therapeutics Committee and Ethics Guidelines for Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents: Growth Hormone Deficiency, Idiopathic Short Stature, and Primary Insulin-Like Growth Factor-I Deficiency. Horm Res Paediatr. 2016; 86(6): 361-397. doi: 10.1159/000452150. epub 2016 Nov 25. pmid: 27884013.
[20] Saenger P, Cohen P. Feeling misguided: a comment on the US guidelines on growth hormone and insulin-like growth factor-I treatment in children and adolescents. Curr Opin Pediatr. 2017 Aug;29(4):472-474. doi: 10.1097/MOP. 0000000000000520. pmid: 28604412.
[21] Geffner ME. For Debate: Combination Growth Hormone and Insulin-Like Growth Factor-I Therapy for Childhood Growth Disorders: Prime Time or Too Much Dime? Pediatr EndocrinolRev. 2018Mar; 15(3): 196-199. doi:10.17458/per. vol15.2018.g.fd.combinationgrowhhormoneandinsuline. pmid: 29493124.
[22] Combined Treatment with Gonadotropin-releasing Hormone Analog and Anabolic Steroid Hormone Increased Pubertal Height Gain and Adult Height in Boys with Early Puberty for Height [J]. Clinical Pediatric Endocrinology, 2012, 21(2): 35-43. doi:10.1297/cpe.21.35.[1]SATOH M, YOKOYA S.
[23] Anabolic steroid and gonadotropin releasing hormone analog combined treatment increased pubertal height gain and adult height in two children who entered puberty with short stature.[J]. Journal of pediatric endocrinology & metabolism: JPEM, 2006, 19(9):1125-1131.
[24] Wit JM, Balen HV, Kamp GA, et al. Benefit of postponing normalpuberty for improving final height [J]. Eur J Endocrinol, 2004 ,151 (Suppl 1): S41- S45.
[25] Zhou F, Hou CHG. Clinical study of Zhibei Dihuang Pill plus Gaiyin Pill combined with lysine in the treatment of dwarf girls in early adolescence [J]. Chinese Traditional Medicine Science and Technology, 2012, 19(03): 204-206+192.
[26] Zhang Yu, Ye Jin. Analysis of the ideas of treating short stature children from the spleen theory[J]. Jiangsu Traditional Chinese Medicine,2018,50(09):43-45.
[27] Wang Yajun, Sun Kaiwei, Ge Xiuyun, Hu Wenmiao, Zhang Lifei, Zhu Hongwen. Rumination on the prevention and treatment of childhood dwarfism from "liver" [J]. Chinese medicine research, 2017, 30(04): 9-10.
[28] Chen, C., Zhan, J., Lan, J. C., Chen, R. K. Collection of Chen RK's experience in identifying and treating dwarfism[J]. Chinese Medicine Bulletin, 2018, 17(02): 19-21+23.
[29] Wang Suting. A preliminary study on factors associated with short stature children and the distribution of body type [D]. Master's degree thesis, Henan College of Traditional Chinese Medicine, 2015.
[30] Zhang Saiping. A questionnaire study on the diagnosis and treatment of short stature in children in Chinese medicine [D]. Master's degree thesis, Nanjing University of Traditional Chinese Medicine, 2018.
[31] Huang Junyi . Clinical efficacy of acupuncture combined with psychotherapy on subhealth insomnia [J]. Chinese Medicine Information, 2015, 32 (6): 86-88.
[32] Ye Yayun, Jin Pal, Yan Lianhe, Zhang Qiaoling. Clinical efficacy of She medical method of pediatric growth and development patch in treating idiopathic short stature in children with earth deficiency and wood hyperactivity constitution [J]. China Modern Doctor, 2019, 57(13): 71-74.
[33] Zhang Hongyan. Pediatric tui na--a "stepping stone" for children to grow taller [J]. Chinese medicine health and wellness, 2018, 4(03): 58-59.
[34] Xiang H, Sun XJ, Chang K, Wang HJ, Zhang Q, Peng Y, Wang Y. Effect of transfer pivot tui na technique combined with recombinant human growth hormone on the growth and development of children with dwarfism [J]. Shaanxi Traditional Chinese Medicine, 2020, 41(06): 766-769.
[35] Guo W, Liu S, Feng HQ. A study on the factors influencing height and psychological status of short children [J]. Contemporary Medicine, 2020, 26(21): 190-192.
[36] Li, H.. Application of recombinant human growth hormone combined with psycho-behavioral intervention for children with idiopathic short stature [J]. Heilongjiang Medical Science, 2020, 43(03): 149-150.

Subscription

E-Mail Alert

Downloads:	4690
Visits:	204439

Advances in Chinese and Western medicine for idiopathic dwarfism

Author(s)

Affiliation(s)

Corresponding Author

ABSTRACT

KEYWORDS

CITE THIS PAPER

REFERENCES

RESOURCES

JOIN US

PUBLICATION SERVICES

CONTACT US